Vaxcyte Inc (PCVX)’s Market Momentum: Closing Strong at 112.10, Up 2.70

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Vaxcyte Inc’s stock clocked out at $112.10, up 2.70% from its previous closing price of $109.15. In other words, the price has increased by $2.70 from its previous closing price. On the day, 5.11 million shares were traded. PCVX stock price reached its highest trading level at $113.64 during the session, while it also had its lowest trading level at $109.73.

Ratios:

To gain a deeper understanding of PCVX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.88 and its Current Ratio is at 17.88. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on December 07, 2023, initiated with a Buy rating and assigned the stock a target price of $69.

Needham reiterated its Buy rating for the stock on January 03, 2023, while the target price for the stock was revised from $52 to $58.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 03 ’24 when Wassil Jim sold 10,000 shares for $111.93 per share. The transaction valued at 1,119,252 led to the insider holds 207,503 shares of the business.

Cowan Elvia sold 5,000 shares of PCVX for $538,350 on Sep 03 ’24. The SVP, FINANCE now owns 12,723 shares after completing the transaction at $107.67 per share. On Sep 03 ’24, another insider, Eydelman Mikhail, who serves as the SVP, GEN COUNSEL & CORP SEC of the company, sold 1,667 shares for $112.11 each. As a result, the insider received 186,880 and left with 30,826 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PCVX now has a Market Capitalization of 12521121792 and an Enterprise Value of 11084327936.

Stock Price History:

Over the past 52 weeks, PCVX has reached a high of $119.27, while it has fallen to a 52-week low of $44.20. The 50-Day Moving Average of the stock is 39.67%, while the 200-Day Moving Average is calculated to be 61.23%.

Shares Statistics:

It appears that PCVX traded 838.42K shares on average per day over the past three months and 1240200 shares per day over the past ten days. A total of 111.61M shares are outstanding, with a floating share count of 106.86M. Insiders hold about 4.26% of the company’s shares, while institutions hold 106.93% stake in the company. Shares short for PCVX as of 1723680000 were 11238839 with a Short Ratio of 13.40, compared to 1721001600 on 11873036. Therefore, it implies a Short% of Shares Outstanding of 11238839 and a Short% of Float of 11.61.

Most Popular